3D holographic measurements meet gold standard

Measurements taken from projected 3D holographic models were able to match a gold standard in measuring accuracy, according to a study set to be presented at the ARRS 2018 Annual Meeting.

3D holographic models developed for education, training and research purposes must mimic the structure of actual models for accuracy. This study, to be presented by Jesus Uribe of the University of California at San Francisco's Helen Diller Medical Center, set out to identify the accuracy and feasibility of projected augmented-reality 3D holographic models.

The 3D models were developed using CT Digital Imaging and Communications in Medicine (DICOM) data. In total, five models were produced, and markers were used to measure the distance between points on the models.

Results examining the accuracy of the measurements taken on the 3D models showed no statistically significance difference when compared to gold standard measurements. Additionally, the 3D hologram model showed high levels of accuracy in nearly approaching PACS measurements.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.